Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients

Joanna Sieniawska, Aleksandra Lesiak, Karol Ciążyński, Joanna Narbutt and Magdalena Ciążyńska
Additional contact information
Joanna Sieniawska: Department of Dermatology, Pediatric Dermatology and Oncology Clinic, Medical University of Lodz, 91-347 Lodz, Poland
Aleksandra Lesiak: Department of Dermatology, Pediatric Dermatology and Oncology Clinic, Medical University of Lodz, 91-347 Lodz, Poland
Karol Ciążyński: Institute of Applied Computer Science, Lodz University of Technology, 90-924 Lodz, Poland
Joanna Narbutt: Department of Dermatology, Pediatric Dermatology and Oncology Clinic, Medical University of Lodz, 91-347 Lodz, Poland
Magdalena Ciążyńska: Department of Dermatology, Pediatric Dermatology and Oncology Clinic, Medical University of Lodz, 91-347 Lodz, Poland

IJERPH, 2022, vol. 19, issue 3, 1-9

Abstract: Atopic dermatitis (AD) can have a significantly negative impact on quality of life (QoL). The impact of coronavirus disease 2019 (COVID-19) on the AD population is not yet well established. The study comprised 195 patients with diagnosed AD who were asked about their cognitive and preventive behaviors regarding COVID-19 and the accessibility of medical support, including online consultations. Moreover, the patients responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale (HADS). Most of the patients were worried about being infected with COVID-19. Most of the patients believed that people suffering from skin disease were more prone to be infected with COVID-19 compared with the general population. Most the patients negatively assessed the availability of dermatological treatment during the pandemic. Furthermore, 66.1% of the patients declared using telemedicine. Nearly 50% of patients were discontented with telemedicine, and 1/3 of the patients did not mind the use of telemedicine. AD during the COVID-19 pandemic was associated with a lower overall health rating and life satisfaction and impaired QoL related to mental health in a Polish population. These results provide original information that can be applied in dermatologic patient screenings to evaluate the state of depression and anxiety during the epidemic period.

Keywords: atopic dermatitis; COVID-19; coronavirus; quality of life (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/3/1734/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/3/1734/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:3:p:1734-:d:741184

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().